Pubblicazioni ufficiali Pharming Group N.V.

Azioni

Mercato chiuso - Euronext Amsterdam Altri mercati azionari 17:35:26 28/06/2024			Variaz. 5gg	Var. 1 gen.
0,7525 ^EUR	-1,18%		+1,07%	-27,01%

31/05	Il Gruppo Pharming segnala un ritardo nella revisione da parte dell'UE del farmaco per le immunodeficienze rare	MT
30/05	Pharming Group N.V. fornisce un aggiornamento sulla revisione regolatoria in corso di Leniolisib per il trattamento dell'Apds nell'Unione Europea	CI

Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	04/08/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	04/08/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	04/08/22	CO
Slide show half-year results	04/08/22	CO
1st-half-year results	04/08/22	CO
1st-half-year results	04/08/22	CO
Admission of new securities	30/06/22	CO
1st quarter results	12/05/22	CO
1st quarter results	12/05/22	CO
Admission of new securities	31/03/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	24/03/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	24/03/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	24/03/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	24/03/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	24/03/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	24/03/22	CO